Reply to :Aminotransferases disorders associated with venous thromboembolic events in patients infected with COVID-19
Ann Hepatol
.
2021 Jul-Aug:23:100334.
doi: 10.1016/j.aohep.2021.100334.
Epub 2021 Feb 20.
Authors
Amer Hamadé
1
,
Bastien Woehl
2
,
Marjolaine Talbot
2
,
Naouel Bensalah
2
,
Pierre Michel
2
,
Golnaz Obringer
2
,
Michèle Lehn-Hogg
2
,
Nathalie Buschenrieder
2
,
Mahdi Issa
3
,
Jonathan Tousch
2
,
Dominique Stephan
4
,
Lucas Jambert
2
Affiliations
1
Service de Médecine Vasculaire, GHRMSA, Hôpital Emile Muller, 20, Rue du Dr Laennec, 68051 Mulhouse, France. Electronic address: hamadea@ghrmsa.fr.
2
Service de Médecine Vasculaire, GHRMSA, Hôpital Emile Muller, 20, Rue du Dr Laennec, 68051 Mulhouse, France.
3
Service de Chirurgie Digestive, GHRMSA, Hôpital Emile Muller, Mulhouse, France.
4
Service d'Hypertension et de Maladies Vasculaires, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
PMID:
33621654
PMCID:
PMC7896488
DOI:
10.1016/j.aohep.2021.100334
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Humans
SARS-CoV-2
Transaminases
Venous Thromboembolism* / diagnosis
Venous Thromboembolism* / epidemiology
Venous Thromboembolism* / etiology
Venous Thrombosis* / diagnosis
Venous Thrombosis* / etiology
Substances
Transaminases